1. Home
  2. ARBE vs XBIT Comparison

ARBE vs XBIT Comparison

Compare ARBE & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd.

ARBE

Arbe Robotics Ltd.

HOLD

Current Price

$1.11

Market Cap

79.1M

Sector

Technology

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.44

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBE
XBIT
Founded
2015
2005
Country
Israel
United States
Employees
144
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.1M
74.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ARBE
XBIT
Price
$1.11
$2.44
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
3.3M
20.1K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$363.94
N/A
Revenue Next Year
$286.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$2.09
52 Week High
$2.88
$3.61

Technical Indicators

Market Signals
Indicator
ARBE
XBIT
Relative Strength Index (RSI) 57.62 48.22
Support Level $0.74 $2.35
Resistance Level $1.17 $2.49
Average True Range (ATR) 0.14 0.06
MACD 0.02 -0.01
Stochastic Oscillator 52.54 42.86

Price Performance

Historical Comparison
ARBE
XBIT

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: